Drug Type AAV based gene therapy |
Synonyms- |
Target |
Action modulators |
Mechanism LAMP-2 modulators(Lysosome-associated membrane glycoprotein 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (European Union) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glycogen Storage Disease Type IIb | Preclinical | United States | 28 Jun 2023 |